341 related articles for article (PubMed ID: 24361143)
1. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
[TBL] [Abstract][Full Text] [Related]
2. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
3. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
5. [Plexiform neurofibroma in the gingiva].
Savaş H; Karabacakoğlu A; Karaköse S; Durmuş E
Tani Girisim Radyol; 2004 Mar; 10(1):39-43. PubMed ID: 15054702
[TBL] [Abstract][Full Text] [Related]
6. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
[TBL] [Abstract][Full Text] [Related]
7. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ
J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214
[TBL] [Abstract][Full Text] [Related]
8. Plexiform neurofibroma of uterus: a rare manifestation of neurofibromatosis 1.
Shahzad R; Younas F
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S22-3. PubMed ID: 24717994
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1: a diagnostic mimicker at CT.
Fortman BJ; Kuszyk BS; Urban BA; Fishman EK
Radiographics; 2001; 21(3):601-12. PubMed ID: 11353109
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
[TBL] [Abstract][Full Text] [Related]
11. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
12. Lumbosacral plexiform neurofibroma: a rare case in an adult without neurofibromatosis type I.
Atkins NK; Stensby JD; Gaballah AH
Skeletal Radiol; 2020 Feb; 49(2):321-330. PubMed ID: 31342092
[TBL] [Abstract][Full Text] [Related]
13. Rare manifestation of Neurofibromatosis type 1: A plexiform neurofibroma involving the mediastinum and lungs with endobronchial neurofibromata.
Pascoe HM; Antippa P; Irving L; Christie M; McCusker MW
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):76-78. PubMed ID: 30238622
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.
Chew DCY; Zhao DBH; Sittampalam K; Kumar SK
J Radiol Case Rep; 2020 Dec; 14(12):1-13. PubMed ID: 33717399
[TBL] [Abstract][Full Text] [Related]
15. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B
Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
17. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
18. Myeloneuropathy due to multiple giant plexiform neurofibromas - an unusual presentation of neurofibromatosis type 1.
Kaur J; Paul BS; Saggar K; Virk JS
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28478391
[No Abstract] [Full Text] [Related]
19. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
Attia S; Guirguis M; Le LQ; Chhabra A
Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.
Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE
Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
